In Search of Better Tools and Capabilities

"We need to do more with less." This is a common theme we hear in our conversations and follow up with Researchers in early phase drug discovery.

To us this translates into better identification and more intense screening of potential therapeutic compounds and targets. Failure is success if it is determined before animal testing.

The foundation being potent, pure and easy to culture primary cells. Then building on the platform with the required media/growth factors, markers, transfection reagents and apoptosis detection kits.

This presentation focuses on our evolving  tools and capabilities in the context of cell based assays and gene expression analysis.